FeesSafety
Pluang+

Crypto prices driven more by borrowing costs and dollar strength than US midterm election results.

Market News
03 Nov 2026, 16:29 WIB
Crypto Briefing
View Source
Neutral
Crypto prices driven more by borrowing costs and dollar strength than US midterm election results.

Bitcoin hovered around $77,300 after the US midterm elections, but political outcomes are unlikely to be the main influence on crypto prices. Ryan Kirkley, CEO of Global Settlement Network, emphasized that factors like borrowing costs, dollar strength, and global liquidity have a stronger impact on investor risk appetite. He noted that while elections can cause volatility, regulatory clarity and economic factors such as cheaper cross-border payments and blockchain adoption will be more decisive for institutional crypto adoption in 2027. Kirkley also highlighted ongoing challenges in US regulatory frameworks and expects Congress to attempt new crypto legislation next year, focusing on clear rules for custody and settlement rather than broad laws.

Regarding Bitcoin and its outlook post-US midterm elections, here is Pluang's market snapshot as of Nov 03, 2026 21:24 WIB: Among 50 major cryptocurrencies priced on Pluang, 20 rose while 29 fell today. Notable movers include BAT at Rp2.295 with a 1-day change of -3.88% and Pluang order activity showing 5% Sell / 95% Buy; CAKE at Rp33.592 with -2.65% and 92% Sell / 8% Buy; and AAVE at Rp2.340.572 with -2.40% and 74% Sell / 26% Buy. Typical hold times range from 75 to 106 days across these assets.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App